Clinical guidance for COVID-19
The Academy’s Ad Hoc Task Force on COVID-19 is monitoring pandemic developments daily, assessing the impact on practices, and providing guidance most relevant to dermatologists. The most current information is being posted to these pages as we have it. Check back for updates.
Access Academy resources designed to answer common dermatology questions during the COVID-19 pandemic.
Review steps you should take to protect yourself, your staff, and your patients.
Access the Academy's statement on the dermatological manifestations of COVID-19.
Access Academy advice and FDA guidance on conserving supplies of PPE and other medical supplies.
Read FDA guidance on flexibility in meeting iPLEDGE requirements during the emergency.
Explore updates and advocacy efforts around ensuring appropriate patient access to hydroxychloroquine.
Review information and documents on continuing immunosuppressive therapies during the COVID-19 pandemic.
Access Academy statements and publications on COVID-19, including DermWorld and JAAD articles.
The ABD recently announced significant changes to its 2020 MOC requirements for dermatologists in light of the COVID-19 pandemic. Learn more about these changes.
CMS has extended the deadline for 2019 MIPS submissions, and is considering how to offer flexibility in 2020.
Navigate the Coronavirus Resource Center
All content solely developed by the American Academy of Dermatology